Fermenta Biotech Reports H1FY27 Financial Results
Fermenta Biotech Ltd 路 Press Release 路 05 Nov 2026, 7:18 pm
Fermenta Biotech Reports H1FY27 Financial Results Fermenta Biotech reported H1FY27 consolidated revenue of INR 261.9 crore (down 7% YoY), EBITDA of INR 45.6 crore (down 34% YoY), and PAT of INR 18.9 crore (down 52% YoY). The decline was primarily driven by lower animal nutrition pricing, where sales dropped 52% YoY to INR 22.1 crore, alongside a high base with prior one-offs. Conversely, Human Nutrition grew 2% YoY to INR 162.5 crore, forming nearly two-thirds of revenue. The India market expanded to 51% of total revenue.
Original exchange filing (PDF)
More announcements from Fermenta Biotech Ltd
- Intimation regarding earnings presentation- Q2/H1FY27. 路 06 Nov 2026
- Intimation regarding the Board''s decision to close the Company''s wholly-owned subsidiary - Fermenta Biotech (UK) Limited. 路 05 Nov 2026
- Outcome of Board Meeting and Unaudited Financial Results (standalone and consolidated) for quarter ended September 30, 2026. 路 05 Nov 2026
- Unaudited financial results (standalone and consolidated) for the quarter ended September 30, 2026. 路 05 Nov 2026
- Fermenta Biotech Limited has submitted to the Exchange, the unaudited financial results (standalone and consolidated) for the period ended September 30, 2026. 路 05 Nov 2026
- FERMENTA BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 05-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 05 Nov 2026
- To consider and approve the unaudited financial results (standalone and consolidated) for the period ended September 30, 2026. 路 05 Nov 2026
- Fermenta Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve unaudited financial results .... 路 05 Nov 2026
